Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04350424 · ClinicalTrials.gov registry record
Driving Skills Recovery Following Procedural Sedation for Gastrointestinal Endoscopy
A clinical trial, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- 68
- Enrollment target
NCT04350424: Clinical Trial study, sponsored by The Cleveland Clinic.
NCT04350424 is a clinical trial that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 68 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04350424 was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- 68 participants
- Enrollment target
Study Summary
This is a prospective cohort study that will analyze psychomotoric recovery using a commercially available driving simulator following sedation for endoscopic procedures in subjects undergoing elective outpatient endoscopic procedures. Patients receiving both propofol based sedation and well as those receiving a combination of fentanyl and midazolam will be studied. Baseline data will be obtained after training on the simulator. Following the procedure and after meeting standard discharge criteria, the subjects will undergo the same driving simulation to ascertain psychomotoric recovery.
Primary Outcome
Simulator Results - number of off road crashes, number of collisions with vehicles and other roadway objects, number of times over the posted speed limit, total number of times the center line was crossed, total number of times the driver went off the road, number of times turn signal not used or used inappropriately).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2019-03-05 |
| Est. Completion | 2020-03-12 |
Why NCT04350424 stopped before completion
NCT04350424 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 68 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04350424 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04350424 about?
NCT04350424 is a clinical study titled "Driving Skills Recovery Following Procedural Sedation for Gastrointestinal Endoscopy". This is a prospective cohort study that will analyze psychomotoric recovery using a commercially available driving simulator following sedation for endoscopic procedures in subjects undergoing elective outpatient endoscopic procedures. Patients receiving both propofol based sedation and well as thos...
What is the current status of trial NCT04350424?
This trial is currently terminated. The enrollment target is 68 participants. The study started on 2019-03-05. Estimated completion is 2020-03-12.
Who is sponsoring clinical trial NCT04350424?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI